APO Research
Talk to an analyst

APO RESEARCH · REPORT

Voltaren

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Voltaren Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025182 pages

Choose your research edition.

Industry ResearchVoltaren Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Voltaren Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Voltaren Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voltaren Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Voltaren Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Voltaren market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Voltaren include Endo Pharmaceuticals, Enovachem Pharmaceuticals, Hainan Quanxing Pharmaceutical, Iroko Pharmaceuticals, Jewim Pharmaceutical, Supor South Ocean, GSK and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Voltaren market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Voltaren and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Voltaren sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Voltaren market size, projected growth trends, production technologies, key applications, and end-use industries.

Voltaren Segment by Company

Endo Pharmaceuticals

Enovachem Pharmaceuticals

Hainan Quanxing Pharmaceutical

Iroko Pharmaceuticals

Jewim Pharmaceutical

Supor South Ocean

GSK

Novartis

Voltaren Segment by Type

Injection

Tablet

Spray

Gel

Capsule

Voltaren Segment by Application

Elderly

Adults

Voltaren Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voltaren market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voltaren and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voltaren.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Voltaren market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Voltaren manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Voltaren in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Voltaren in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Voltaren Industry Trends Table 2. Voltaren Industry Drivers Table 3. Voltaren Industry Opportunities and Challenges Table 4. Voltaren Industry Restraints Table 5. Global Voltaren Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Voltaren Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Voltaren Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Voltaren Sales Market Share by Manufacturers Table 9. Global Voltaren Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Voltaren Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Voltaren Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Voltaren Manufacturers, Product Type & Application Table 13. Global Voltaren Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Voltaren by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Tablet Table 18. Major Manufacturers of Spray Table 19. Major Manufacturers of Gel Table 20. Major Manufacturers of Capsule Table 21. Global Voltaren Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Voltaren Sales by Type (2021-2026) & (K Units) Table 23. Global Voltaren Sales by Type (2027-2032) & (K Units) Table 24. Global Voltaren Sales Market Share by Type (2021-2026) Table 25. Global Voltaren Sales Market Share by Type (2027-2032) Table 26. Global Voltaren Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Voltaren Revenue by Type (2021-2026) & (K Units) Table 28. Global Voltaren Revenue by Type (2027-2032) & (K Units) Table 29. Global Voltaren Revenue Market Share by Type (2021-2026) Table 30. Global Voltaren Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Elderly Table 32. Major Manufacturers of Adults Table 33. Global Voltaren Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Voltaren Sales by Application (2021-2026) & (K Units) Table 35. Global Voltaren Sales by Application (2027-2032) & (K Units) Table 36. Global Voltaren Sales Market Share by Application (2021-2026) Table 37. Global Voltaren Sales Market Share by Application (2027-2032) Table 38. Global Voltaren Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Voltaren Revenue by Application (2021-2026) & (K Units) Table 40. Global Voltaren Revenue by Application (2027-2032) & (K Units) Table 41. Global Voltaren Revenue Market Share by Application (2021-2026) Table 42. Global Voltaren Revenue Market Share by Application (2027-2032) Table 43. Global Voltaren Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Voltaren Sales by Region (2021-2026) & (K Units) Table 45. Global Voltaren Sales Market Share by Region (2021-2026) Table 46. Global Voltaren Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Voltaren Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Voltaren Sales by Country (2021-2026) & (K Units) Table 50. North America Voltaren Sales by Country (2027-2032) & (K Units) Table 51. Europe Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Voltaren Sales by Country (2021-2026) & (K Units) Table 53. Europe Voltaren Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Voltaren Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Voltaren Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Voltaren Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Voltaren Sales by Country (2027-2032) & (K Units) Table 60. Global Voltaren Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Voltaren Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Voltaren Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Voltaren Revenue Market Share by Region (2021-2026) Table 64. Global Voltaren Revenue Market Share by Region (2027-2032) Table 65. Endo Pharmaceuticals Company Information Table 66. Endo Pharmaceuticals Business Overview Table 67. Endo Pharmaceuticals Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Endo Pharmaceuticals Voltaren Product Portfolio Table 69. Endo Pharmaceuticals Recent Development Table 70. Enovachem Pharmaceuticals Company Information Table 71. Enovachem Pharmaceuticals Business Overview Table 72. Enovachem Pharmaceuticals Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Enovachem Pharmaceuticals Voltaren Product Portfolio Table 74. Enovachem Pharmaceuticals Recent Development Table 75. Hainan Quanxing Pharmaceutical Company Information Table 76. Hainan Quanxing Pharmaceutical Business Overview Table 77. Hainan Quanxing Pharmaceutical Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Hainan Quanxing Pharmaceutical Voltaren Product Portfolio Table 79. Hainan Quanxing Pharmaceutical Recent Development Table 80. Iroko Pharmaceuticals Company Information Table 81. Iroko Pharmaceuticals Business Overview Table 82. Iroko Pharmaceuticals Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Iroko Pharmaceuticals Voltaren Product Portfolio Table 84. Iroko Pharmaceuticals Recent Development Table 85. Jewim Pharmaceutical Company Information Table 86. Jewim Pharmaceutical Business Overview Table 87. Jewim Pharmaceutical Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Jewim Pharmaceutical Voltaren Product Portfolio Table 89. Jewim Pharmaceutical Recent Development Table 90. Supor South Ocean Company Information Table 91. Supor South Ocean Business Overview Table 92. Supor South Ocean Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Supor South Ocean Voltaren Product Portfolio Table 94. Supor South Ocean Recent Development Table 95. GSK Company Information Table 96. GSK Business Overview Table 97. GSK Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. GSK Voltaren Product Portfolio Table 99. GSK Recent Development Table 100. Novartis Company Information Table 101. Novartis Business Overview Table 102. Novartis Voltaren Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Novartis Voltaren Product Portfolio Table 104. Novartis Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Voltaren Distributors List Table 108. Voltaren Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Voltaren Product Image Figure 2. Global Voltaren Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voltaren Market Size (2021-2032) & (US$ Million) Figure 4. Global Voltaren Sales (2021-2032) & (K Units) Figure 5. Global Voltaren Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Voltaren Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Tablet Image Figure 10. Spray Image Figure 11. Gel Image Figure 12. Capsule Image Figure 13. Global Voltaren Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Voltaren Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Voltaren Sales Market Share by Type (2021-2032) Figure 16. Global Voltaren Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Voltaren Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Voltaren Revenue Market Share by Type (2021-2032) Figure 19. Elderly Image Figure 20. Adults Image Figure 21. Global Voltaren Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Voltaren Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Voltaren Sales Market Share by Application (2021-2032) Figure 24. Global Voltaren Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Voltaren Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Voltaren Revenue Market Share by Application (2021-2032) Figure 27. North America Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Voltaren Sales Market Share by Country (2021-2032) Figure 29. U.S. Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Voltaren Sales Market Share by Country (2021-2032) Figure 34. Germany Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Voltaren Sales Market Share by Country (2021-2032) Figure 41. China Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Voltaren Sales Market Share by Country (2021-2032) Figure 49. Brazil Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Voltaren Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Voltaren Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Voltaren Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Voltaren Revenue (2021-2032) & (US$ Million) Figure 60. North America Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Voltaren Revenue (2021-2032) & (US$ Million) Figure 62. Europe Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Voltaren Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Voltaren Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Voltaren Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Voltaren Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Spray
  • Gel
  • Capsule
Applications
  • Elderly
  • Adults
Companies covered
  • Endo Pharmaceuticals
  • Enovachem Pharmaceuticals
  • Hainan Quanxing Pharmaceutical
  • Iroko Pharmaceuticals
  • Jewim Pharmaceutical
  • Supor South Ocean
  • GSK
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Voltaren Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Voltaren Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Voltaren Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Voltaren Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Voltaren Market Dynamics
  1. 2.1 Voltaren Industry Trends
  2. 2.2 Voltaren Industry Drivers
  3. 2.3 Voltaren Industry Opportunities and Challenges
  4. 2.4 Voltaren Industry Restraints
3 Voltaren Market by Manufacturers
  1. 3.1 Global Voltaren Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Voltaren Sales by Manufacturers (2021-2026)
  3. 3.3 Global Voltaren Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Voltaren Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Voltaren Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Voltaren Manufacturers, Product Type & Application
  7. 3.7 Global Voltaren Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Voltaren Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Voltaren Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Voltaren Tier 1, Tier 2, and Tier 3
4 Voltaren Market by Type
  1. 4.1 Voltaren Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablet
  4. 4.1.3 Spray
  5. 4.1.4 Gel
  6. 4.1.5 Capsule
  7. 4.2 Global Voltaren Sales by Type
  8. 4.2.1 Global Voltaren Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Voltaren Sales by Type (2021-2032)
  10. 4.2.3 Global Voltaren Sales Market Share by Type (2021-2032)
  11. 4.3 Global Voltaren Revenue by Type
  12. 4.3.1 Global Voltaren Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Voltaren Revenue by Type (2021-2032)
  14. 4.3.3 Global Voltaren Revenue Market Share by Type (2021-2032)
5 Voltaren Market by Application
  1. 5.1 Voltaren Application Introduction
  2. 5.1.1 Elderly
  3. 5.1.2 Adults
  4. 5.2 Global Voltaren Sales by Application
  5. 5.2.1 Global Voltaren Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Voltaren Sales by Application (2021-2032)
  7. 5.2.3 Global Voltaren Sales Market Share by Application (2021-2032)
  8. 5.3 Global Voltaren Revenue by Application
  9. 5.3.1 Global Voltaren Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Voltaren Revenue by Application (2021-2032)
  11. 5.3.3 Global Voltaren Revenue Market Share by Application (2021-2032)
6 Global Voltaren Sales by Region
  1. 6.1 Global Voltaren Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Voltaren Sales by Region (2021-2032)
  3. 6.2.1 Global Voltaren Sales by Region (2021-2026)
  4. 6.2.2 Global Voltaren Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Voltaren Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Voltaren Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Voltaren Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Voltaren Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Voltaren Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Voltaren Revenue by Region
  1. 7.1 Global Voltaren Revenue by Region
  2. 7.1.1 Global Voltaren Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Voltaren Revenue by Region (2021-2026)
  4. 7.1.3 Global Voltaren Revenue by Region (2027-2032)
  5. 7.1.4 Global Voltaren Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Voltaren Revenue (2021-2032)
  8. 7.2.2 North America Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Voltaren Revenue (2021-2032)
  11. 7.3.2 Europe Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Voltaren Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Voltaren Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Voltaren Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Endo Pharmaceuticals
  2. 8.1.1 Endo Pharmaceuticals Company Information
  3. 8.1.2 Endo Pharmaceuticals Business Overview
  4. 8.1.3 Endo Pharmaceuticals Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Endo Pharmaceuticals Voltaren Product Portfolio
  6. 8.1.5 Endo Pharmaceuticals Recent Developments
  7. 8.2 Enovachem Pharmaceuticals
  8. 8.2.1 Enovachem Pharmaceuticals Company Information
  9. 8.2.2 Enovachem Pharmaceuticals Business Overview
  10. 8.2.3 Enovachem Pharmaceuticals Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Enovachem Pharmaceuticals Voltaren Product Portfolio
  12. 8.2.5 Enovachem Pharmaceuticals Recent Developments
  13. 8.3 Hainan Quanxing Pharmaceutical
  14. 8.3.1 Hainan Quanxing Pharmaceutical Company Information
  15. 8.3.2 Hainan Quanxing Pharmaceutical Business Overview
  16. 8.3.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Quanxing Pharmaceutical Voltaren Product Portfolio
  18. 8.3.5 Hainan Quanxing Pharmaceutical Recent Developments
  19. 8.4 Iroko Pharmaceuticals
  20. 8.4.1 Iroko Pharmaceuticals Company Information
  21. 8.4.2 Iroko Pharmaceuticals Business Overview
  22. 8.4.3 Iroko Pharmaceuticals Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Iroko Pharmaceuticals Voltaren Product Portfolio
  24. 8.4.5 Iroko Pharmaceuticals Recent Developments
  25. 8.5 Jewim Pharmaceutical
  26. 8.5.1 Jewim Pharmaceutical Company Information
  27. 8.5.2 Jewim Pharmaceutical Business Overview
  28. 8.5.3 Jewim Pharmaceutical Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jewim Pharmaceutical Voltaren Product Portfolio
  30. 8.5.5 Jewim Pharmaceutical Recent Developments
  31. 8.6 Supor South Ocean
  32. 8.6.1 Supor South Ocean Company Information
  33. 8.6.2 Supor South Ocean Business Overview
  34. 8.6.3 Supor South Ocean Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Supor South Ocean Voltaren Product Portfolio
  36. 8.6.5 Supor South Ocean Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK Voltaren Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Voltaren Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Voltaren Product Portfolio
  48. 8.8.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Voltaren Value Chain Analysis
  2. 9.1.1 Voltaren Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Voltaren Production Mode & Process
  6. 9.2 Voltaren Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Voltaren Distributors
  9. 9.2.3 Voltaren Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst